Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;21(8):2919-2921.
doi: 10.1111/ajt.16702. Epub 2021 Jun 18.

Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients

Affiliations

Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients

Monica Miele et al. Am J Transplant. 2021 Aug.
No abstract available

Keywords: clinical research/practice; immunobiology; infection and infectious agents-viral; infectious disease; organ transplantation in general; vaccine.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) Anti-SARS-CoV-2 S1/S2 IgG concentration in solid organ transplant recipients (SOTRs) (n = 16) compared to ICs (n = 23). The horizontal bars correspond to the median value, respectively, 3.8 AU/ml in SOTRs and 212 AU/ml in immunocompetent subjects (ICs). Samples with anti-SARS-CoV-2 S1/S2 IgG concentration >15 AU/ml were considered positive. The dotted line corresponds to threshold. (B) T cell responses (IFN-γ ELISpot SFC per 106 PBMC) to Spike (Mix I and II, respectively, of 158 and 157 peptides derived from a peptide scan, 15mers with 11 aa overlap) (p < .0001), or CEF (p = .08), were compared between ICs (n = 23) and SOTRs (n = 16). Each dot plot represents normalized mean spot count from duplicate wells (2.5 ± 0.5 × 105 PBMC/well) for each subject, after subtraction of spots count of unstimulated cells (the medium with peptides pool diluent-only). Circles under the graphics are representative of ELISpot from each group against Spike and CEF peptide pools. Bold black line represents the median and dotted line the experimental threshold (95 SFC per 106 PBMC). The significance was determined using a Mann-Whitney U-test (two-sides), ****p < .0001

References

    1. Blumberg EA, Manuel O, Sester M, Ison MG. The future of SARS-CoV-2 vaccines in transplant recipients: to be determined [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16598. Epub ahead of print. - DOI - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786. doi: 10.1001/jama.2021.4385. - DOI - PMC - PubMed
    1. Marinaki S, Adamopoulos S, Degiannis D, et al. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16607. Epub ahead of print. - DOI - PMC - PubMed
    1. Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16615. Epub ahead of print. - DOI - PMC - PubMed
    1. Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant. 2021;21(3):938–949. doi: 10.1111/ajt.16295. - DOI - PubMed